SCHEMBL31190819

SCHEMBL31190819

CC(C)(C)OC(=O)N1CC(F)(F)C2(CC2)C1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NR1H2 P55055 2/20 0.39
HPGD P15428 1/20 0.36
EPHX2 P34913 1/20 0.36
GPR183 P32249 1/20 0.36
RECQL P46063 1/20 0.35
EPHX1 P07099 1/20 0.35
USP30 Q70CQ3 1/20 0.33
CYP11B2 P19099 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
HTT P42858 1/20 0.33
ATM Q13315 1/20 0.33
ACACB O00763 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31190652 0.90 USP2 (0.42) USP2SMN1; SMN2NR1H2HPGDEPHX2
SCHEMBL24746957 0.89 NR1H2 (0.38) USP2SMN1; SMN2NR1H2HPGDEPHX2
SCHEMBL12445298 0.87 USP2 (0.48) USP2SMN1; SMN2NR1H2HPGDEPHX2
SCHEMBL31343939 0.87 USP2 (0.44) USP2SMN1; SMN2NR1H2HPGDEPHX2
SCHEMBL1604637 0.87 USP2 (0.44) USP2SMN1; SMN2NR1H2HPGDEPHX2
SCHEMBL30918959 0.85 NR1H2 (0.39) USP2SMN1; SMN2NR1H2HPGDEPHX2
SCHEMBL21981358 0.85 USP2 (0.40) USP2SMN1; SMN2NR1H2HPGDEPHX2
SCHEMBL27033390 0.84 CHRM2 (0.40) USP2SMN1; SMN2NR1H2HPGDEPHX2
SCHEMBL31486863 0.84 NR1H2 (0.36) USP2SMN1; SMN2NR1H2HPGDEPHX2
SCHEMBL20669250 0.81 EPHX2 (0.38) USP2SMN1; SMN2EPHX2GPR183EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024220747-A2 FLUORINATED CYCLIC DERIVATIVES OF SULFONAMIDES AND SULFONES, AND COMPOSITIONS AND METHODS THEREOF Lysoway Therapeutics, Inc. (US) 2024-10-24 WO disclosed